Symptoms of Pheochromocytoma
Pheochromocytoma should be suspected in any patient presenting with the classic triad of episodic headaches, palpitations, and sweating, particularly when accompanied by severe or resistant hypertension. 1
Classic Symptom Triad
The most diagnostically significant symptoms are:
- Headaches (pooled sensitivity 60.4%) 2
- Palpitations (pooled sensitivity 59.3%) 2
- Diaphoresis/sweating (pooled sensitivity 52.4%) 2
When all three symptoms occur together in a hypertensive patient, the diagnostic specificity approaches 90% for pheochromocytoma. 3 This classic triad has a positive likelihood ratio of 6.3 and a negative likelihood ratio of 0.14, making it highly valuable when present. 2
Cardiovascular Manifestations
Hypertension Patterns
- Severe hypertension is the hallmark finding, with pooled sensitivity of 80.7% 1, 2
- Resistant hypertension (systolic ≥190 mmHg despite multi-drug therapy) is particularly characteristic 3
- Paroxysmal hypertension superimposed on sustained hypertension 1, 4
- Importantly, approximately 15% of patients have no history of hypertension, making normotension insufficient to exclude the diagnosis 1
Cardiac Symptoms
- Tachycardia and cardiac arrhythmias 1
- Palpitations with or without chest pain 1
- Systolic heart failure and ST-segment changes mimicking myocardial infarction 5
- QT interval prolongation and rarely ventricular tachycardia 5
- Signs of congestive heart failure on examination 1
Autonomic and Metabolic Symptoms
- Anxiety attacks or sense of impending doom 1
- Weight loss despite adequate caloric intake 1
- Excessive sweating beyond what hypertension alone would cause 1
- Facial flushing and intermittent pallor 3
- Tremor and tremulousness 3, 6
- Nausea accompanying hypertensive episodes 3
Episodic Nature
Approximately 95% of patients experience paroxysmal symptoms, while about 50% have sustained hypertension between episodes. 3 These "spells" or attacks can be:
- Spontaneous or triggered by specific activities 7
- Provoked by certain medications (see below) 1, 7
- Associated with blood pressure lability 4
Physical Examination Findings
Key findings to assess include:
- Blood pressure and pulse measurement in both upper and lower extremities 1
- Orthostatic hypotension (sensitivity 23-50%, variable definitions) 2
- Displaced apical impulse suggesting left ventricular hypertrophy from chronic catecholamine exposure 3
- Persistent tachycardia despite beta-blockade 3
- Excessive sweating and anxiety on examination 1
- Skin stigmata of neurofibromatosis (café-au-lait spots, neurofibromas) if associated with genetic syndrome 4
Atypical Presentations
The clinical manifestations can be highly variable and may mimic many other diseases. 6 Some patients present with:
- No typical triad symptoms 8
- Absence of obvious clinical signs with only imaging and biochemical abnormalities 8
- Cardiovascular emergencies without preceding typical symptoms 5
- Incidental adrenal mass discovered on imaging for unrelated reasons 1, 7
Critical Clinical Pitfalls
Medication-Provoked Symptoms
Certain medications can trigger catecholamine release and should raise suspicion:
- Tricyclic antidepressants 1
- Decongestants and sympathomimetics 1
- Amphetamines and other stimulants 1
- Metoclopramide and other dopamine antagonists 7
Dangerous Management Errors
Beta-blocker monotherapy in untreated pheochromocytoma is potentially hazardous and may precipitate unopposed alpha-adrenergic stimulation leading to hypertensive crisis. 3 This occurs because blocking beta-2 mediated vasodilation leaves alpha-1 vasoconstriction unopposed.
When to Suspect Pheochromocytoma
Test for pheochromocytoma in these clinical settings 7:
- Paroxysmal symptoms of headache, palpitations, and sweating
- Resistant hypertension despite adequate therapy
- Adrenal incidentaloma with or without hypertension
- Young patients (<40 years) with severe hypertension 3
- Family history of pheochromocytoma or associated syndromes (MEN 2, von Hippel-Lindau, neurofibromatosis, familial paraganglioma) 1, 9
- Previous history of pheochromocytoma 7
Diagnostic Delay
The mean interval from symptom onset to definitive diagnosis is approximately 3 years, highlighting the importance of clinical recognition. 3 Autopsy series demonstrate that pheochromocytomas contributed to 55% of deaths and were clinically unsuspected in 75% of cases, underscoring the frequency of missed diagnoses. 3
Initial Diagnostic Approach
When pheochromocytoma is suspected based on symptoms:
- Measure plasma free metanephrines (99% sensitivity, 89% specificity) as the preferred initial test 3
- Alternatively, obtain 24-hour urinary fractionated metanephrines (77-97% sensitivity, 69-98% specificity) 1
- Discontinue interfering medications before testing: tricyclic antidepressants, decongestants, amphetamines, reserpine, and phenoxybenzamine 1, 3
- Plasma metanephrine levels exceeding 3-4 times the upper reference limit are highly diagnostic 1, 3